Peter Island Baby SunscreenSPF 50 (AMWAY CORP.)
Welcome to the PulseAid listing for the Peter Island Baby Sunscreen drug offered from AMWAY CORP.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | AMWAY CORP. |
NON-PROPRIETARY NAME: | HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE |
SUBSTANCE NAME: | HOMOSALATE; OXYBENZONE; AVOBENZONE; OCTISALATE; OCTOCRYLENE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | TOPICAL |
DOSAGE FORM: | LOTION |
MARKETING CATEGORY NAME: | OTC MONOGRAPH NOT FINAL |
START MARKETING DATE: | 2012-11-26 |
END MARKETING DATE: | 0000-00-00 |
Peter Island Baby Sunscreen SPF 50 HUMAN OTC DRUG Details:
Item Description | Peter Island Baby Sunscreen SPF 50 from AMWAY CORP. |
LABELER NAME: | AMWAY CORP. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 13; 4; 3; 5; 7(g/100g; g/100g; g/100g; g/100g; g/100g) |
START MARKETING DATE: | 2012-11-26 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 50390-706_710ba90e-e8ac-498d-8971-3f6777f9c094 |
PRODUCT NDC: | 50390-706 |
APPLICATION NUMBER: | part352 |
Other HOMOSALATE; OXYBENZONE; AVOBENZONE; OCTISALATE; OCTOCRYLENE Pharmaceutical Manufacturers / Labelers: